Literature DB >> 10233858

Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.

M H Vermeer1, F A Geelen, J A Kummer, C J Meijer, R Willemze.   

Abstract

Granzyme B (GrB) and T-cell-restricted intracellular antigen (TIA-1) are cytotoxic proteins that are specifically expressed by cytotoxic CD4 or CD8 positive T cells and natural killer cells. Recent studies demonstrated frequent expression of GrB and TIA-1 by neoplastic cells in primary cutaneous CD30(+) large T-cell lymphomas and lymphomatoid papulosis but not in CD30(-) large T-cell lymphomas. In the present study, 74 biopsies from 54 patients with mycosis fungoides (MF) were investigated for the expression of GrB and TIA-1 using immunohistochemistry on paraffin sections. Staining of more than 10% of the neoplastic T cells for GrB or TIA-1 was considered positive. All but two follow-up biopsies had been obtained from patients without extracutaneous disease at the time of biopsy. Expression of TIA-1 and GrB was found in 33 (45%) and 14 (19%) of 74 MF biopsies, respectively. Comparison of biopsies from T3NoMo-stage MF (n = 27) and T2NoMo-stage MF (n = 45) showed increased expression of TIA-1 (55 versus 37%) and GrB (33 versus 9%) in T3NoMo-stage MF. Evaluation of multiple sequential biopsies from successive stages of MF also revealed an increase in the GrB/TIA-1 expression with tumor progression in five of eight cases. A clearcut relation between the expression of TIA-1 and/or GrB and the type of skin lesion biopsied was found. Considering all 74 biopsies, expression of TIA-1 and GrB was found in 18 of 50 (35%) and 5 of 50 (10%) patches or plaques, 9 of 16 (55%) and 3 of 16 (20%) tumors without blastic transformation, and 6 of 8 (75%) and 6 of 8 (75%) tumors with blastic transformation (defined as >50% blast cells). Correlation between GrB/TIA-1 expression in first diagnostic biopsies from patches or plaques from 40 patients with T2NoMo-stage MF and clinical follow-up data did not reveal differences in clinical behavior and survival between patients with (n = 14) or without (n = 26) expression of cytotoxic proteins, indicating that MF expressing cytotoxic proteins should not be considered as a separate group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233858      PMCID: PMC1866574          DOI: 10.1016/S0002-9440(10)65372-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.

Authors:  P Anderson; C Nagler-Anderson; C O'Brien; H Levine; S Watkins; H S Slayter; M L Blue; S F Schlossman
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

Review 2.  Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells.

Authors:  G M Griffiths; C Mueller
Journal:  Immunol Today       Date:  1991-11

Review 3.  Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases.

Authors:  C J Froelich; V M Dixit; X Yang
Journal:  Immunol Today       Date:  1998-01

4.  Structure and function of human perforin.

Authors:  M G Lichtenheld; K J Olsen; P Lu; D M Lowrey; A Hameed; H Hengartner; E R Podack
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

5.  Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes.

Authors:  O Krähenbühl; C Rey; D Jenne; A Lanzavecchia; P Groscurth; S Carrel; J Tschopp
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

6.  Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture.

Authors:  B Fleischer
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

7.  Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process.

Authors:  J P Greer; K E Salhany; J B Cousar; J P Fields; L E King; S E Graber; J M Flexner; R S Stein; R D Collins
Journal:  Hematol Oncol       Date:  1990 Jul-Aug       Impact factor: 5.271

8.  Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins.

Authors:  J A Kummer; A M Kamp; M van Katwijk; J P Brakenhoff; K Radosević; A M van Leeuwen; J Borst; C L Verweij; C E Hack
Journal:  J Immunol Methods       Date:  1993-07-06       Impact factor: 2.303

9.  The 5'-flanking region of the human CGL-1/granzyme B gene targets expression of a reporter gene to activated T-lymphocytes in transgenic mice.

Authors:  R D Hanson; G M Sclar; O Kanagawa; T J Ley
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

10.  Cytotoxic potential of intraepithelial lymphocytes (IELs). Presence of TIA-1, the cytolytic granule-associated protein, in human IELs in normal and diseased intestine.

Authors:  G J Russell; C Nagler-Anderson; P Anderson; A K Bhan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more
  4 in total

1.  NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome.

Authors:  Pierre Schneider; Louis-François Plassa; Philippe Ratajczak; Christophe Leboeuf; Laurence Verneuil; Maxime Battistella; Armand Bensussan; Martine Bagot; Anne Janin
Journal:  J Invest Dermatol       Date:  2013-07-30       Impact factor: 8.551

2.  Unusual variants of mycosis fungoides.

Authors:  Pooja Virmani; Patricia L Myskowski; Melissa Pulitzer
Journal:  Diagn Histopathol (Oxf)       Date:  2016-05-21

3.  Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.

Authors:  D F Dukers; M H Vermeer; L H Jaspars; C A Sander; M J Flaig; W Vos; R Willemze; C J Meijer
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

4.  Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.

Authors:  Xiangjun Liu; Shanzhao Jin; Simeng Hu; Ruoyan Li; Haihao Pan; Yi Liu; Pan Lai; Deshu Xu; Jingru Sun; Ziyang Liu; Yumei Gao; Yifan Zhao; Fengjie Liu; Yu Xiao; Yingyi Li; Yujie Wen; Zhuojing Chen; Bufang Xu; Yuchieh Lin; Menglong Ran; Qianxi Li; Shuxia Yang; Hang Li; Ping Tu; Muzlifah Haniffa; Sarah A Teichmann; Fan Bai; Yang Wang
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.